A cikin yanayin da ke ci gaba da haɓakawa na biopharmaceuticals, neman hanyoyin samar da inganci da dorewa yana da mahimmanci. Kwanan nan, abokin ciniki ya kusanci SINAEKATO don gwada gwajin homogenizer na zamani, musamman don samar da emulsion ta amfani da manne kifi azaman abinci.
Wannan gwajin gwajin ya yi niyya ne don gano yuwuwar kayan abinci mai ƙarfi na alkaline don haɓaka tsarin emulsification. Manne kifi, wanda aka samo daga collagen na fatun kifi da kasusuwa, ya sami kulawa a aikace-aikacen biopharmaceutical saboda rashin daidaituwa da yanayin halitta. Kaddarorinsa na musamman sun sa ya zama ɗan takara mai kyau don ƙirƙirar emulsion masu ƙarfi, waɗanda ke da mahimmanci a cikin tsarin isar da magunguna da ƙirar rigakafin. Abokin ciniki ya nemi yin amfani da SINAEKATO ta ci-gaba homogenization fasaha don inganta emulsion samar da tsari, tabbatar da uniform barbashi size da ingantattun kwanciyar hankali. A lokacin gwajin gwaji, an sanya homogenizer ta ƙwaƙƙwaran kimantawa don tantance ingancinsa wajen sarrafa kayan abinci mai ƙarfi na alkaline.
An san yanayin alkaline don yin tasiri ga solubility da danko na manne kifin, wanda zai iya tasiri sosai ga tsarin emulsification. Ta hanyar daidaita sigogi kamar matsa lamba, zafin jiki, da lokacin sarrafawa, ƙungiyar ta yi niyyar gano mafi kyawun yanayi don cimma halayen emulsion da ake so. Sakamako daga gwajin sun kasance masu ban sha'awa, suna nuna ikon homogenizer don samar da ingantattun emulsions tare da ingantaccen kwanciyar hankali da kuma bioavailability.
Wannan ci gaban zai iya ba da hanya don ingantattun hanyoyin samar da magunguna na biopharmaceutical, a ƙarshe suna amfana da masana'antar kiwon lafiya. A ƙarshe, haɗin gwiwa tsakanin SINAEKATO da abokin ciniki yana nuna mahimmancin fasahar sabbin fasahohi a cikin sashin biopharmaceutical. Yayin da buƙatun hanyoyin samar da dorewa da inganci ke ci gaba da haɓaka, nasarar gwajin homogenizer tare da manne kifin da abinci mai ƙarfi na alkaline yana nuna babban ci gaba a cikin samar da emulsion.
Lokacin aikawa: Dec-17-2024